Wise John Drayton — SEC insider filings
SEC reporting owner CIK 1930805. 16 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2022-05-25 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 12 filings — 73,150 shares, $3,026,790 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 10,000 shares @ $65.98 ($659,800) in INSMED Inc, filed 2025-01-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSMED Inc (INSM) | Chief Commercial Officer | 14 | — | 20 legs · 73,150 sh · $3,026,790 | 19 |
| IRulya Therapeutics Inc. (IRLA) | Director | 2 | — | — | 1 |
Insider filings — Wise John Drayton
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | IRulya Therapeutics Inc. (IRLA) | Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2026-10-19 | 3 | IRulya Therapeutics Inc. (IRLA) | Holdings only — no transactions reported | EDGAR |
| 2025-02-07 | 4 | INSMED Inc (INSM) | Grant/award (A): 15,373 @ $0 · Sale (S): 7,910 @ $80.90 · Sale (S): 10 @ $78.91 | EDGAR |
| 2025-01-10 | 4 | INSMED Inc (INSM) | Option exercise (M): 10,000 @ $16.07 · Sale (S): 10,000 @ $65.98 · Sale (S): 2,908 @ $65.87 · Sale (S): 392 @ $66.21 · Grant/award (A): 6,657 · Sale (S): 287 @ $65.40 · +2 more | EDGAR |
| 2024-05-30 | 4 | INSMED Inc (INSM) | Sale (S): 1,602 @ $48.95 · Option exercise (M): 6,250 @ $12.58 · Sale (S): 6,250 @ $50 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 14,518 · Sale (S): 5,088 @ $25.47 · Grant/award (A): 71,160 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | INSMED Inc (INSM) | Sale (S): 1,861 @ $28.78 | EDGAR |
| 2024-01-05 | 4 | INSMED Inc (INSM) | Option exercise (M): 20,071 @ $19.11 · Sale (S): 20,071 @ $29.19 · Grant/award (A): 12,873 · Sale (S): 1,167 @ $29.32 · Option exercise (M): 20,071 (derivative) @ $0 · Grant/award (A): 63,560 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | INSMED Inc (INSM) | Sale (S): 3,366 @ $18.95 | EDGAR |
| 2023-05-17 | 4 | INSMED Inc (INSM) | Sale (S): 593 @ $19.29 · Sale (S): 381 @ $18.44 · Sale (S): 1,913 @ $18.17 | EDGAR |
| 2023-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 31,662 · Grant/award (A): 146,220 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | INSMED Inc (INSM) | Sale (S): 779 @ $17.96 | EDGAR |
| 2023-01-06 | 4 | INSMED Inc (INSM) | Sale (S): 1,160 @ $19.74 · Grant/award (A): 7,598 · Grant/award (A): 34,860 (derivative) @ $0 | EDGAR |
| 2022-11-22 | 4 | INSMED Inc (INSM) | Sale (S): 7,154 @ $18.84 | EDGAR |
| 2022-08-12 | 4 | INSMED Inc (INSM) | Sale (S): 258 @ $27.79 | EDGAR |
| 2022-05-25 | 4 | INSMED Inc (INSM) | Grant/award (A): 26,236 · Grant/award (A): 164,580 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1930805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs